Faculty Collaboration Database -

CURRICULUM VITAE

Ekokobe Fonkem DO

Chair, Professor
Department of Neurology
Division of Administration


OFFICE ADDRESS:
Hub for Collaborative Medicine
8701 Watertown Plank Road
Milwaukee, WI 53226
Email: efonkem@mcw.edu


EDUCATION:
09/1999 - 12/2000 Pre-Medicine (AA), University of Wisconsin Colleges, Fox Valley, WI
01/2000 - 12/2002 Bachelor of Science (BSc) in Biochemistry (Magna cum laude), University of Wisconsin-Madison, Madison, WI
08/2003 - 05/2007 Doctor of Osteopathic Medicine, Ohio University College of Osteopathic Medicine, Athens, OH


POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/2007 - 08/2008 Internship, Ohio State University Medical Center, Columbus, OH
09/2008 - 07/2011 Residency, Ohio State University Medical Center, Columbus, OH
07/2011 - 06/2012 Neuro-Oncology Fellowship, Harvard University Beth Israel Medical Center, Boston, MA
06/2017 - 06/2018 American Society of Clinical Oncology Leadership Development Fellowship, Alexandria, VA


FACULTY APPOINTMENTS:
07/2007 - 08/2008 Clinical Instructor of Medicine, Ohio State University Medical Center, Columbus, OH
09/2008 - 08/2011 Clinical Instructor of Neurology, Ohio State University Medical Center, Columbus, OH
07/2012 - 05/2017 Assistant Professor of Surgery, Texas A&M Health Science Center, College of Medicine, Temple, TX
05/2017 - 11/2019 Associate Professor of Surgery, Texas A&M Health Science Center, College of Medicine, Temple, TX
11/2019 - 12/2022 William Shapiro Endowed Chair of Neuro-Oncology, Barrow Neurological Institute, Phoenix, AZ
11/2019 - 12/2022 Associate Professor of Neurology, University of Arizona and Creighton University College of Medicine, AZ
01/2022 - 06/2023 Associate Professor of Surgery, Texas A&M Health Science Center, College of Medicine Temple, TX
06/2023 - Present Professor of Neurology, Neurosurgery and Oncology, Medical College of Wisconsin, Milwaukee, WI
07/2023 - Present Visiting Professor of Medicine, University of Health and Allied Sciences, University of Dar-esalam, Tanzania


ADMINISTRATIVE APPOINTMENTS:
11/2019 - 12/2022 Chief of Division of Neuro-Oncology, Barrow Neurological Institute, Phoenix, AZ
01/2022 - 06/2023 Chief of Neuro-Oncology Division, Baylor Scott and White Health, Temple, TX
06/2023 - Present Chair of the Department of Neurology, Medical College of Wisconsin, Milwaukee, WI
06/2023 - Present Member, Wisconsin Neuroscience Institute Executive Committee, Medical College of Wisconsin, Fredeit Health System, Wisconsin Children’s and the Veteran Affairs Hospital, Milwaukee, WI
06/2023 - Present Member and Neurology Chair, Dean and Provost Clinical Chairs Governance Council, Medical College of Wisconsin, Milwaukee, WI


EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
05/2003 - 08/2003 Anatomy Instructor. Summer Enrichment Program., Anatomy Instructor. Summer Enrichment Program., Wisconsin Madison, WI
05/2005 - 08/2005 Anatomy Instructor. Summer Enrichment Program., Ohio University, Athens, OH
05/2006 - 08/2006 Anatomy Instructor. Summer Enrichment Program., Ohio University, Athens, OH
07/2012 - 11/2019 System Director of Neuro-Oncology Program, Baylor Scott & White Health Neuroscience and Cancer Institutes, Temple, TX
02/2020 - 01/2022 Founder and Director of Africa Neuro-Oncology Fellowship, Barrow Neurological Institute, Phoenix, AZ
2020 - Present Co-Founder. Barrow Global Neuroscience Program, Phoenix, AZ
01/2022 - 06/2023 System Director of Neuro-Oncology Program, Baylor Scott & White Health Neuroscience and Cancer Institutes, Temple, TX


HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
07/2012 - 05/2017 Neurologist and Neuro-Oncologist, Baylor Scott &White Health System, Temple, TX
01/2022 - 06/2023 Co-Chair. Baylor Scott and White Health System Wide Neuro-oncology Committee, TX
08/02/2023 - Present FMLH Medical Executive Committee, Froedtert Memorial Lutheran Hospital, Medical College of Wisconsin, Milwaukee, WI 53226


RESEARCH ADMINISTRATIVE APPOINTMENTS:
02/2013 - 11/2019 Founder and Director of Brain Tumor Bank, Baylor Scott & White Health Neuroscience and Cancer Institutes, TX


SPECIALTY BOARDS AND CERTIFICATION:


Board Certified	Issue Date	Expiration
Neurologist	2012	None
Neuro-Oncologist	2021	None


Certificates	Issued By	Issue Date	Expiration
Doctor of Osteopathic Medicine	Arizona Board of Osteopathic Medical Examiners	2019	None


Licensure	Number	Issue Date	Expiration
Doctor of Osteopathic Medicine		2010	None
Doctor of Osteopathic Medicine		2011	2014
Doctor of Osteopathic Medicine		2012	None


AWARDS AND HONORS:
1999 - 2000 American Chemical Society Scholar Award, American Chemical Society (ACS)
1999 - 2000 Douglas Salmon Scholarship Award, UW Fox Valley.
2000 Minority Medical Education Fellowship Award, Case Western Reserve University. Cleveland, OH.
2001 Summer Research Fellowship Award, University of Wisconsin-Madison
2002 Minority International Research Fellow Award, NIH/University of Dar Es Salaam, Tanzania.
2003 Best Biochemistry Student, University of Wisconsin-Madison, WI.
2004 Biomedical Student of the Year Award, Ohio University College of Osteopathic Medicine
2010 Resident Research of the Year Award, Dept. of Neurology, Ohio State University. Columbus
2010 NIH Travel Grant for the NIH Minority Research Meeting., NIH
2011 NIH-NMA Scholar Award, National Institutes of Health / National Medical Association
2012 Outstanding Alumni Award, University of Wisconsin Fox Valley.
2014 Dr. Marnie Rose Foundation Award. Brain Tumor Research.
2016 Dr. Marnie Rose Foundation Award. Brain Tumor Research and Community Engagement.
2017 American Society of Clinical Oncology Leadership Development Fellowship. , American Society of Clinical Oncology (ASCO)
2021 Barrow Foundation Award to Support International Neuro-Oncology Fellowship Program for Brain Cancer Experts from Sub Saharan Africa.
2021 Arizona Diamond Backs for Glioblastoma. The award was accompanied by 1,530,000 USD to support research in Brain Tumor Diagnosis and Treatment.
2021 CARIS POA Precision Oncology Alliance Award. Caris Life Sciences as Leader in Precision Medicine.


MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2003 - Present American Osteopathic Association
2003 - Present American Medical Association
2008 - Present American Academy of Neurology
2012 - Present American Society of Clinical Oncology
2012 - Present Society of Neuro-Oncology (SNO)
2017 - Present Society of Neuro-Oncology Sub Saharan Africa (SNOSSA)
2017 - Present Association of Cameroonians Physicians in Americas (ACPA)
2021 - Present Society for Physician Entrepreneurs


EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorial Board
2013 - Present Chemotherapy Journal
2016 - Present Clinics in Oncology.
2016 - Present Section Editor, Journal Neurology and Neuromedicine
2022 - Present Frontiers of Oncology
2022 - Present Frontiers of Neuro-Oncology and Neurosurgery.
2022 - Present Special Edition Editor, Frontiers of Cancer Pain.
2023 - Present Cancer
Ad-Hoc Reviewer
2013 - Present Frontiers of Neurology
2013 - Present Cancer Medicine
2013 - Present Frontiers of Oncology
2014 - Present Journal of Neurological Disorders and Stroke
2017 - Present Baylor Scott and White University Medical Proceedings
2017 - Present Journal of Oncology Practice
2017 - Present Journal of Global Oncology
2017 - Present Journal of Clinical Oncology
2019 - Present Journal of Neuro-Oncology
2020 - Present Ceures


LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2010 - 2019 Member, Member. Baylor Scott and White Internal Research Foundation Grant Review Committee
2015 - 2019 Member, Baylor Scott and White / Texas A&M Neurology Residency Program Admission Committee
2015 - 2019 Member, Baylor Scott and White Neurology Residency Admission Committee
2016 - 2019 Member, Baylor Scott and White System Neuroscience Research Committee
2016 - 2019 Member, Baylor Scott and White at Waco Executive Cancer Committee
2017 - Present Appointed Full Member, Livestrong Cancer Institute at UT Dell Medical
2017 - Present Member, Abstract Reviewer. Society of Neuro-Oncology Annual Meetings
2019 - 2022 Member, Barrow Neurological Institute CMO
2019 - 2020 Chief Research Officer, Advisory Council, Barrow Neurological Institute CMO
2019 - 2022 Member, Barrow Neurological Institute Neurology Residency Admission Committee
2020 - 2022 Member, Budget Committee, Dignity Health System, Phoenix, AZ, USA
2020 - 2022 Appointed Member, Dignity Health CEO Governing Council.
2021 - 2022 Executive Board Member. Barrow IVY Brain Tumor Center.
2022 - Present Member, Baylor Scott and White Neurosurgery Residency Admission Committee, Baylor Scott and White


NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2014 - Present Member of Advisory Board, Cleanint
2017 - Present Executive Member, Steering Committee of ASCO Conquer Cancer Foundation
2017 - Present Advisory Board Member, Tekzone
2018 - Present Member, Conquer Cancer Foundation Grant Review and Selection Committee, American Society of Clinical Oncology (ASCO)
2019 - Present Member, Minority Committee, Society of Neuro-Oncology (SNO)
2019 - Present Site Principal Investigator., NIH Brain Tumor Trials Collaborative (BTTC).
2019 - Present Member, Caris Life Science Precision Oncology Alliance CNS Group.
2019 - Present Board Member, National Meningioma Network
2019 - Present Member, NRG Oncology (the National Surgical Adjuvant Breast and Bowel Project, the Radiation Therapy Oncology Group, and the Gynecologic Oncology Group).
11/2020 Co-Chair, SNO CNS Survivorship Annual meeting. Society of Neuro-Oncology (SNO)
2020 - Present CNS Oncology Board Member, Cancer Commons
2020 - Present Member, Society for Neuro-Oncology Women and Diversity Committee
2020 - Present Member, COVID-19 and Cancer Research Consortium.
2022 - Present Member, Steering Committee in Charge of Fundraising, Association of Cameroonians Physicians in Americas (ACPA)


INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2017 - Present Member, Global Oncology Committee, American Society of Clinical Oncology (ASCO)
2017 - Present Co-founder/Executive Steering Committee member, Society for Neuro-oncology Sub-Saharan Africa (SNOSSA)
2017 - Present Member, Steering Committee, SNO Sub Sahara African Working Group
2020 - Present Member, African Brain Tumor Registry and Biobanking Consortium.
2020 - Present Co-chair, African Brain Tumor Registry and Biobanking Consortium.
06/2023 Member, Abstract Reviewer, Society for Neuro-oncology Sub-Saharan Africa (SNOSSA)
07/2023 Co-Chair, Annual Meeting 2023, Society for Neuro-oncology Sub-Saharan Africa (SNOSSA)
2023 - Present Member, Executive Committee of the Association of Cameroon Physicians in the Americas (ACPA).
2023 - Present Member, Scientific and Educational Committee, Society for Neuro-oncology Sub-Saharan Africa (SNOSSA)

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:


Active
Peer Review
Title:	Multi-parametric Perfusion MRI for Therapy Response Assessment in Brain Cancer.
Source:	NIH/NCI 1UG3CA247606-01
Role:	Co-Investigator
Dates:	07/01/2020 - 06/30/2025
Direct Funds:	$300,000

Title:	18F-Fluciclovine PET imaging for distinguishing tumor progression from treatment-related effects in glioblastoma patients undergoing radiochemotherapy.
Source:	Barrow Neurological Foundation
Role:	Co-Investigator
Dates:	07/01/2021 - 09/01/2023
Direct Funds:	$125,000

Title:	Integration of whole blood and image-based biomarkers for early prediction of glioblastoma recurrence
Source:	NIH/NCI
Role:	MPI (Quarles, Fonkem E, Wu, Li), Role: Principal Investigator
Dates:	09/01/2021 - 08/30/2026
Direct Funds:	$450,000 (Grant was reviewed and received a percentile score of 13%. Pending funding)

Title:	Combination of PI3kinase with Immune Checkpoint Inhibitor for treatment of High-Grade Glioma.
Source:	AL Musella Foundation
Role:	Principal Investigator
Dates:	10/01/2022 - 10/31/2023
Direct Funds:	$25,000

Title:	Phase 2 study of Ketogenic diet plus standard of care treatment of newly diagnosed glioblastoma.
Source:	NIH/NCI
Role:	Site Principal Investigator
Dates:	10/01/2022 - 07/30/2027
Direct Funds:	$432,000


Prior
Peer Review
Title:	Fonkem 120791 Brain Bank- Scott and White Neuroscience Institute Brain Bank
Source:	Baylor Scott and White
Role:	Principal Investigator
Dates:	02/2012 - 06/2023
Direct Funds:	$400,000

Title:	Novocure Phase 3 Clinical Trial for Newly Diagnosed Glioblastoma Patients with adjuvant temozolomide plus or minus Novo.TTF 100A therapy.
Source:	Novocure
Role:	Principal Investigator
Dates:	03/2013 - 03/2015
Direct Funds:	$250,000

Title:	EF-14- A prospective multi-center trial of novoTTF-100A together with temozolomide compared to temozolomide alone in patients with newly diagnosed GBM.
Source:	Novocure
Role:	Principal Investigator
Dates:	09/20/2013 - 10/31/2014
Direct Funds:	$250,000

Title:	Phase 3 Clinical Trial for treatment of recurrent glioblastoma
Source:	Nativis
Role:	Principal Investigator
Dates:	01/2016 - 09/2018
Direct Funds:	$150,000

Title:	Startrk-2 - An open Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements (Protocol RXDX-101-02)
Source:	Genetek
Role:	Sub investigator
Dates:	03/2016 - 11/2019
Direct Funds:	$158,000

Title:	Forma FT-2102- A phase 1b/2 Study of FT-2102 in patients with advanced solid tumors and gliomas with an IDH1 mutation.
Source:	Forma Therapeutics
Role:	Principal Investigator
Dates:	06/2016 - 11/2019
Direct Funds:	$120,000

Title:	A Phase 3, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma that Progress/Recur after Irradiation and Adjuvant Temozolomide Chemotherapy (STELLAR Study).
Source:	Orbus Therapeutics
Role:	Principal Investigator / Sub investigator
Dates:	07/2016 - 01/2021
Direct Funds:	$170,000

Title:	Goal: To evaluate new mutations identified in a glioblastoma family
Source:	Project grant from Baylor Scott & White Health Foundation Plummer Chair.
Role:	Principal Investigator
Dates:	07/2016 - 06/2020
Direct Funds:	$50,000

Title:	Study of subjects with newly diagnosed glioblastoma (GBM) with Epidermal Growth Factors Receptors Amplifications (EGFR).
Source:	Abbvie
Role:	Principal Investigator
Dates:	05/2017 - 05/2018
Direct Funds:	$400,000

Title:	EF-25- METIS: Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)
Source:	Novocure
Role:	Principal Investigator/Sub-investigator
Dates:	07/2017 - 01/2021
Direct Funds:	$350,000

Title:	AbbVie. - Phase 3 B Trial Study for Management of Ocular Side Effects in Subjects with EGFR Amplified Glioblastoma Receiving Depatuxizumab Mafodotin (ABT-414).
Source:	Abbvie
Role:	Principal Investigator
Dates:	07/2017 - 12/2019
Direct Funds:	$1,500,000

Title:	CD44 160280 – Prognosis and therapeutic biomarkers for glioblastoma patients.
Source:	NovoCure Inc
Role:	Principal Investigator
Dates:	08/2017 - 08/2019
Direct Funds:	$250,000

Title:	Greg Wilkins-Barrick International Outreach Course in Neuro-Oncology for sub-Saharan Africa. Society for Neuro-Oncology.
Source:	Society for Neuro-Oncology
Role:	Principal Investigator
Dates:	12/2017 - 12/2020
Direct Funds:	$90,000

Title:	RTOG 0834/EORTC 26053_NCIC CTG ECE.1-Phase lll trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non1p/19q Deleted Anaplastic Glioma: The CATNON Intergroup Trial
Source:	NRG
Role:	Principal Investigator
Dates:	2017 - 2021
Direct Funds:	$250,000

Title:	Navitis A Feasibility Study of the Nativis Voyager System in Patients with Newly Diagnosed GBM.
Source:	Emulate Pharmaceutical
Role:	Principal Investigator
Dates:	03/2018 - 02/2019
Direct Funds:	$199,000

Title:	Blood and saliva Biomarkers for GBM- Identification of Biomarkers from Biological Fluids for Early Detection of Glioblastoma Multiforme (GBM) Combined Use of Global Gene Expression Profiling and Proteomics Mass Spectrometry.
Source:	Baylor Scott and White Foundation
Role:	Principal Investigator
Dates:	06/2018 - 06/2023
Direct Funds:	$50,000

Title:	Establishing the Validity of Brain Tumor Perfusion Imaging
Source:	NIH/NCI 2R01 CA213158-01 07/01/2021-06/30/2026
Role:	Co-Investigator
Dates:	11/16/2019 - 01/10/2021
Direct Funds:	$400,000

Title:	Development of Biomarkers for the Diagnosis of Brain Tumors Using Saliva and Liquid Biopsies.
Source:	Barrow and Beyond Foundation Genius
Role:	Principal Investigator
Dates:	11/2020 - 11/2021
Direct Funds:	$113,000


INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Regional
“Neuro-Oncological Emergencies”, Barrow Neurological Institute Ground Rounds, Phoenix, AZ, 08/2020
“Are disparities in brain cancer Care purely environmental or have any molecular basis?”, Caris POA Precision Oncology alliance group, Phoenix, AZ, 06/2021

National
“Hormonal Regulation of Pre-optic regulating factor (Porf 2) in Rat FRTL-5 Thyroid Cells”., Annual Society of Neuroscience, Washington, DC, 04/2006
“Neuropathy after Lung Transplantation: Insights into the Effects of Dysglycemia”, Society of Clinical Neurology, Portland, Maine, 06/2009
“Ethambutol Toxicity Exacerbating the Phenotype of CMT2A2”., American Academy of Neurology Annual Meeting, Toronto, Canada, 04/2010
“The Natural History of Intravascular Lymphoma”, American Academy of Neurology Annual Meeting, New Orleans, LA, 11/2012
“Metabolic Disruption as a mechanism to potentiate Temozolomide therapy in glioblastoma multiforme”, Society of Neuro-Oncology Annual Meeting, San Francisco, CA, 11/2013
“The incidence of astrocytoma at an integrated health care system: the experience of Scott & White Health Care System”., Society of Neuro-Oncology Annual Meeting, San Francisco, CA, 11/2013
“Spectrum of Neurological Presentation of Intravascular Lymphoma”., Society of Neuro-Oncology (SNO) Annual Meeting, San Francisco, CA, 11/2013
“Identification of salinomycin's novel therapeutic binding targets in neuroblastoma”., Celebration of Scholarship, Dickinson State University. Dickinson, ND, 2013
“Identification and clinical prognosis of Salinomycin binding targets in neuroblastoma”, ASPET Annual Meeting, San Diego, CA, 03/2014
“Identification of two salinomycin binding targets in neuroblastoma”., Graduate School Research and Art Forum. NDSU Memorial Union, Fargo, ND, 2014
“Identification of two salinomycin binding targets in neuroblastoma”., Mid-West Pharm Fest, Fargo, ND, 2014
“Updates in the Management of Primary Brain Tumors”, Austin Neuropsychological Association, Austin, Texas, 10/2015
“Survival Outcomes Prognostication in Glioblastoma Diagnosed Patients”., Society of Neuro-Oncology (SNO) Annual Meeting, San Antonio, TX, 11/2015
“A Retrospective Study to Explore Prognostic Factors for Ependymoma Survival”, Society of Neuro-Oncology (SNO) Annual Meeting, San Antonio, TX, 11/2015
“Differential tumor graft acceptance of 261 Giloblastoma Multitform (GBM) cell lines between lines wild type C5B16, CD74 deficient, and Gamma Delta TCR deficient mice”., Society for Neuroscience (SFN) - 2015, 2015
"Metabolic disruption potentiates temozolomide cytotoxicity in glioblastoma", SFN, 2015
“The Natural History of Intravascular Lymphoma”, Neurology Grand Rounds, Mayo Clinic, 04/2016
“Neurological Presentations of Intravascular Lymphoma”, Neurology Grand Rounds, Medical College of Wisconsin, 08/2016
“Survival Outcomes in Glioblastoma Patients Using TTFields: The Baylor Scott and White Medical Center in Central Texas Experience”., Society for Neuro-Oncology (SNO) Annual Meeting, New Orleans, LA, 11/2018
“The Natural History of T cell Intravascular Lymphoma”, Society for Neuro-Oncology (SNO) Annual Meeting, New Orleans, LA, 11/2018
“Current Controlled Nitinol Wire for Improved arterial Navigation”, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance System XVII, Boston, MA, USA., 03/2019
“CD44 as potential therapeutic target for Medulloblastoma metastasis”., AACR Annual Meeting, San Antonio, Texas, 07/2019
"A Preliminary Report on Quality of Life and Sexual Function in Brain Cancer Patients", The Society for Neuro-Oncology (SNO) Annual Meeting, Austin, TX, 11/2019
“Feasibility Study of the Emulate Therapeutics Voyager System in Patients with Newly Diagnosed Glioblastoma”, Annual Society for Neuro-Oncology (SNO) Meeting, Scottsdale, AZ, 11/2019
“Phase 1 Study of FT-2102, Inhibitor of Mutant IDH 1, in patients with Relapsed/ Refractory IDH 1 mutant Gliomas: Preliminary Safety and Clinical Activity, Annual Society for Neuro-Oncology (SNO) Meeting, Scottsdale, AZ, 11/2019
“Feasibility Study of the Emulate Therapeutics Voyager System in Patients with Recurrent Glioblastoma.”, Annual Society for Neuro-Oncology (SNO) Meeting, Scottsdale, AZ, USA, 11/2019
“A systemic Review of Central Nervous System Tumors in Africa from 1960- 2017 and they need for a Central Brain Tumor Registry in Africa”., Annual SNO meeting, Austin, TX, 04/2020
10. “BRAF mutation is an early event in the evolution of a subset of Glioblastoma and is associated with increased PD-L1 expression.”, Annual Society for Neuro-Oncology Meeting, Austin, TX, 11/2020
“Identifying Vulnerability Signatures through Machine Learning in an Umbrella Trial for Glioblastoma”, Annual Society for Neuro-Oncology Meeting, Austin, TX, 11/2020
“Identifying Vulnerability Signatures through Machine Learning in an Umbrella Trial for Glioblastoma”, Annual SNO meeting, Austin, TX, 11/2020
The neurological complications of Chemo Therapies, American Academy of Neurology annual meeting, Seattle, Washington, USA, 04/2022
“Molecular Characterization and Management of High-Grade Gliomas”, Idea Oncology Educational Service, McAllen TX, 05/2022
“MCW Neurology 2.0 Opportunities and Challenges”, Neurology Grand Rounds, Medical College of Wisconsin, 12/2022
“PI3 kINASES Inhibitors for the treatment of high gliomas”., Myammar Baptist Centre. Florida, 03/2023

International
“Current treatments of Glioblastoma”, China National Defense University Neuroscience Symposium, Beijing, China, 03/2015
“Updates on the Management of Glioblastoma”., First Annual Meeting of the Society of Neuro-Oncology, Sub-Saharan Africa, Abuja, Nigeria, 07/2018
“Tumor Treating Field Updates”., Asian Society for Neuro-Oncology Annual Meeting, Xian, China, 03/2019
“Ask the Expert in Brain Tumor”, Society for Neuro-oncology of Sub-Saharan Africa (SNOSSA), Cape Town, South Africa, 08/2019
Keynote Address, “Need for Brain Tumor Registry for Sub Saharan Africa”, 4th Annual Meeting for the Society for Neuro-Oncology Sub Saharan Africa (SNOSSA), Held virtually, due to the ongoing COVID-19 pandemic, 08/2021
“Clinical Trial Design and Protocol Development”., Fifth Annual Meeting for the Society for Neuro-Oncology Sub Saharan Africa (SNOSSA), University of Legon, Ghana, 07/2022
“Need of African Brain Tumor Banking and Tumor Registries”, Fifth Annual Meeting for the Society for Neuro-Oncology Sub Saharan Africa (SNOSSA), University of Legon, Ghana, 07/2022
“Telemedicine Opportunities in Neuro-Oncology”, European Society for Oncology Annual Meeting (EANO), Vienna, Austria, 09/2022
Vignettes in Neuro-oncology, Society for Neuro-oncology Sub-Saharan Africa (SNOSSA) Annual Meeting, Nairobi, Kenya, 07/2023
“Neuro-oncological Emergencies”., Society for Neuro-oncology Sub-Saharan Africa (SNOSSA) Annual Meeting, Nairobi, Kenya, 07/2023


EXTRAMURAL TEACHING:
Medical Student Education
2009 - 2011 Ohio State University Medical School, Neurological Procedure (Lumbar puncture didactics and techniques)
2019 - 2022 University of Arizona and Creighton University College of Medicine, Overview of Brain Tumors for Medical Students

Resident and Fellow Education
2020 - 2022 Barrow Neurological Institute, Phoenix, AZ, USA., Founder and Lead. Fellowship program for medical students, residents, fellows, and physicians from developing countries. Training the next generation of educators and leaders in neuro-oncology from Africa and Latin America.

Continuing Medical Education
2012 - 2019 Baylor Scott and White Health, Neuro-oncology Tumor Board. A multidisciplinary collaboration between all the different sub-specialties that deal with Neuro-oncology.
06/2017 - 06/2018 American Society of Clinical Oncology, Development and Implementation of the ASCO Continued education curriculum. American Society of Clinical Oncology Oncologists Recertification.
10/18/2017 - 10/20/2017 Society of Neuro-Oncology (SNO), Sub-Saharan Africa Neuro-oncology Collaborative (S-SANOC), Dr. Thierry Muanza, Dr. Ekokobe Fonkem, Dr. Gaspar J. Kitange, Dr. Hamisi K Shabani (S-SANOG), Kathy Oliver (IBTA): “SNO Wilkins-Barrick International Outreach Course Proposal Sub-Saharan Africa Neuro-Oncology Group”, Tanzania Group 1. Society of Neuro-Oncology (SNO), Sub-Saharan Africa Neuro-oncology Collaborative (S-SANOC) Planning Meeting, 18-20 October 2017, London UK.
07/2022 Society for Neuro-oncology Sub-Saharan Africa (SNOSSA), Course Director. Pre-conference workshop. SNOSSA Symposium: Introduction to Clinical Trial Design and Protocol Development: July 22nd, 1-5pm GMT. Accra, Ghana.
2022 - 2023 Baylor Scott and White Health, Neuro-oncology Tumor Board. A multidisciplinary collaboration between all the different sub-specialties that deal with Neuro-oncology.
07/2023 Society for Neuro-oncology Sub-Saharan Africa (SNOSSA), Co-chair of Pre-Conference Educational Workshop. Co-lead for Medical Neuro-oncology

Graduate Student Education
2013 - 2016 Texas A&M Graduate School, Translational Neuroimmunology with Dr. Karen Rogers
2022 - Present Texas A&M Graduate School, Translational Neuroimmunology with Dr. Karen Rogers


EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
Undergraduate Students
Darin Garrett (BS)., Texas A&M University, TX, USA., 2013 - 2014 Faculty Mentor
Ryan Shepherd, (BS)., Baylor University, Waco TX, USA., 2014 - 2015 Faculty Mentor
Chandler Graf, (BS), Abilene Christian University, Abilene TX, 2015 Faculty
Kaiyang Feng (BS0, University of Arkansas, Little Rock, Arkansas, USA., 2017 - 2019 Faculty Mentor
Amanda Johnson (BS)., Houston Baptist University, Houston, TX, USA., 2017 - 2019 Faculty Mentor
Adam Tamini, University of North Texas, TX, USA., 2021 - Present Faculty Mentor
Eva Bradshaw, University of North Texas, TX, USA., 2021 - Present Faculty Mentor

Medical Students
Paul Bricker (BS), Texas A & M Health Science College of Medicine, 2012 - 2016 Faculty Mentor
Adeline Kikam (BS), Heritage College of Osteopathic Medicine, 2012 - Present Faculty Mentor
Marilyn Feb, Walden University., 2018 - Present Faculty Mentor, PhD/Medical Student

Graduate Students
PhD Students Advised
Jennifer Griffin (MS), Texas A& M University, Bryan, TX, United States., 2012 - 2014, PhD Advisor
MS Students Advised
Blessing Tateh (MPH), University of Buea, 2022 - Present

Clinical/Research Fellows
Sanjib Muhkarjee (MBBS, PhD), Baylor Scott and White and Texas A& M University Health Sciences, TX, USA., 2014 - 2018 Faculty Mentor, Translational and Clinical Research Fellow
Marilyn Feh (PhD), Centre for Disease Control and Prevention (CDC). Atlanta, Georgia, 2018 - Present Faculty Mentor, Research Fellow
Ambe Solomon (MD), Baylor Scott and White, TX, USA., 2018 - 2021 Faculty Mentor, Clinical Research Fellow
Chuck Ekhator (MBBS, MPH), New York Institute of Technology College of Osteopathic Medicine., 2020 - Present Faculty Mentor, Research Fellow
Lateef Odukoya (MBBS), Barrow Neurological Institute. Phoenix, AZ, USA., 2021 - 2022 Faculty Mentor, International Neuro-oncology Fellow
Ramya Tadipatri (MD), Barrow Neurological Institute, Phoenix, AZ, USA., 2021 - 2022 Faculty Mentor, Neuro-oncology Fellow
Joachim Mabula (MBBS), Barrow Neurological Institute, Phoenix, AZ, USA., 2021 - 2022 Faculty mentor, International Neuro-oncology Fellow
Ambe Solomon (MD), University of Texas, Houston, TX, USA, 2021 - 2022 Faculty Mentor, Neuro-Physiology Fellow

Residents
Adeline Kikam (DO), . McAllen General Hospital. McAllen Texas, USA, 2016 - 2020 Faculty Mentor, Ambe Solomon (MD),
Ambe Solomon (MD), Tulane University Medical Centre, New Orleans, Louisiana, USA., 2017 - 2021 Faculty Mentor, Neurology Resident
Ramya Tadipatri (MD), Barrow Neurological Institute, Phoenix, AZ, US, 2019 - 2021 Faculty Mentor, Neurology Resident
Valerie Sharf (MD), Barrow Neurological Institute, Phoenix, AZ, US, 2020 - 2021 Faculty Mentor, BNI Neurology Resident
Ada Breitenbucher (MD), Barrow Neurological Institute, Phoenix, AZ, US, 2021 - 2022 Faculty Mentor, BNI Neurology Resident
Adela Miller (DO), Barrow Neurological Institute, Phoenix, AZ, US, 2021 - 2022 Faculty Mentor, BNI Neurology Resident


PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Fellow
2020 - Present Barrow Global Neuroscience Program


COMMUNITY SERVICE ACTIVITIES:
2014 - Present CEO and Founder. Fonkem Neuro-oncology Consulting, PLLC.
2019 - Present Founder, President and CEO. Tanzifarm LLC
2020 - 2022 Chief Medical Officer (CMO). Sorogi Health A remote monitoring company to help better manage chronic diseases such high blood pressure, diabetes, obesity in underserved communities.
2021 - Present Member of the Advisory Board. Chris Elloit Brain Foundation
2022 - Present Special Adviser and Content Expert. “Better Place Foundation”. Dedicated to finding the Cure for Brain Tumor


GLOBAL HEALTH ACTIVITIES:
2009 - Present Founder and CEO. Healing Beyond the Horizon
2020 - Present Member of the Health Committee. Lebang Cultural and Development Organization (LECUDO), USA.
2023 - Present Special Adviser to HE Ambassador Dr. John Nkengasong. Health Related Issues in Cameroon and Sub-Sahara Africa.


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Leeper HE, Tonorezos E, Mayer D, Bakitas M, Chang S, Cooley ME, Hervey-Jumper S, Miaskowski C, Sherwood P, Tsien C, Wallgren K, Willmarth N, Arons D, Acquaye A, King AL, Penas-Prado M, Vera E, Gilbert MR, Armstrong TS, NCI-CONNECT Survivorship Care in Neuro-Oncology Workshop . Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT). Neurooncol Adv. 2022;4(1):vdac029. PMCID: PMC9079897
2. Fonkem E, Tadipatri R, Newton HB. Overview of pathology and treatment of intramedullary spinal cord metastases Handbook of Neuro-Oncology Neuroimaging. 1 January 2022:59-63.
3. Newton HB, Tadipatri R, Fonkem E. Overview of pathology and treatment of metastatic brain tumors Handbook of Neuro-Oncology Neuroimaging. 1 January 2022:25-37.
4. Fonkem E, Tadipatri R, Newton HB. Overview of spinal cord tumour epidemiology Handbook of Neuro-Oncology Neuroimaging. 1 January 2022:39-43.
5. Newton HB, Fonkem E. Overview of pathology and treatment of primary brain tumours Handbook of Neuro-Oncology Neuroimaging. 1 January 2022:9-24.
6. Newton HB, Fonkem E. Overview of pathology and treatment of primary spinal cord tumours Handbook of Neuro-Oncology Neuroimaging. 1 January 2022:45-58.
7. Newton HB, Tadipatri R, Fonkem E. Overview of brain tumour epidemiology Handbook of Neuro-Oncology Neuroimaging. 1 January 2022:3-8.
8. Mortensen MJ, Oatman O, Azadi A, Fonkem E, Yuen KC. An Update on Immune Checkpoint Inhibitor-related Hypophysitis US Endocrinology. 2020;16(2):117-124.
9. Olafsen LJ, Jones B, Sparks L, Nguyen HH, Tanner A, Schubert KE, Olafsen JS, Dayawansa S, Fonkem E, Huang JH. Current-controlled Nitinol wire for improved arterial navigation Progress in Biomedical Optics and Imaging - Proceedings of SPIE. 2019;10868.
10. Nizamutdinov D, Graf KC, Dayawansa S, Kirmani B, Wu E, Huang JH, Fonkem E. Prognostication, treatment strategies and clinical outcomes in ependymoma diagnosed patients Ependymomas: Prognostic Factors, Treatment Strategies and Clinical Outcomes. 1 January 2016:13-30.
11. Nizamutdinov D, Graf KC, Dayawansa S, Kirmani B, Wu E, Huang JH, Fonkem E. Prognostication, treatment strategies and clinical outcomes in ependymoma diagnosed patients Ependymomas: Prognostic Factors, Treatment Strategies and Clinical Outcomes. 1 January 2016:13-30.
12. Bates ME, Liu LY, Esnault S, Stout BA, Fonkem E, Kung V, Sedgwick JB, Kelly EA, Bates DM, Malter JS, Busse WW, Bertics PJ. Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils. Am J Respir Cell Mol Biol. 2004 May;30(5):736-43.
13. Fonkem E, Lun M, Wong ET. Rare phenomenon of extracranial metastasis of glioblastoma. J Clin Oncol. 2011 Dec 01;29(34):4594-5.
14. Fonkem E, Wong ET. NovoTTF-100A: a new treatment modality for recurrent glioblastoma. Expert Rev Neurother. 2012 Aug;12(8):895-9.
15. Fonkem E, Uhlmann EJ, Floyd SR, Mahadevan A, Kasper E, Eton O, Wong ET. Melanoma brain metastasis: overview of current management and emerging targeted therapies. Expert Rev Neurother. 2012 Oct;12(10):1207-15.
16. Floyd SR, Kasper EM, Uhlmann EJ, Fonkem E, Wong ET, Mahadevan A. Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial. Front Oncol. 2012;2:122. PMCID: PMC3472503
17. Fonkem E, Skordilis MA, Binkley EM, Raymer DS, Epstein A, Arnold WD, Kissel JT, Lawson VH. Ethambutol toxicity exacerbating the phenotype of CMT2A2. Muscle Nerve. 2013 Jul;48(1):140-4.
18. Bernett A, Phenis R, Fonkem E, Aceves J, Kirmani B, Cruz-Laureano D. Neurobehavioral effects of levetiracetam in brain tumor related epilepsy. Front Neurol. 2013;4:99. PMCID: PMC3717617
19. Zhou S, Wang F, Wong ET, Fonkem E, Hsieh TC, Wu JM, Wu E. Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. Curr Med Chem. 2013;20(33):4095-101. PMCID: PMC4102832
20. Aceves J, Khan O, Mungall D, Fonkem E, Wright C, Wenner A, Kirmani B. Efficacy and tolerability of intravenous levetiracetam in childrens. Front Neurol. 2013;4:120. PMCID: PMC3743038
21. Fonkem E, Bricker P, Mungall D, Aceves J, Ebwe E, Tang W, Kirmani B. The role of levetiracetam in treatment of seizures in brain tumor patients. Front Neurol. 2013 Oct 07;4:153. PMCID: PMC3791389
22. Wright C, Downing J, Mungall D, Khan O, Williams A, Fonkem E, Garrett D, Aceves J, Kirmani B. Clinical pharmacology and pharmacokinetics of levetiracetam. Front Neurol. 2013 Dec 04;4:192. PMCID: PMC3850169
23. Kirmani BF, Robinson DM, Kikam A, Fonkem E, Cruz D. Selection of antiepileptic drugs in older people. Curr Treat Options Neurol. 2014 Jun;16(6):295.
24. Fonkem E, Lok E, Robison D, Gautam S, Wong ET. The natural history of intravascular lymphomatosis. Cancer Med. 2014 Aug;3(4):1010-24. PMCID: PMC4303169
25. Wang F, Remke M, Bhat K, Wong ET, Zhou S, Ramaswamy V, Dubuc A, Fonkem E, Salem S, Zhang H, Hsieh TC, O'Rourke ST, Wu L, Li DW, Hawkins C, Kohane IS, Wu JM, Wu M, Taylor MD, Wu E. A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma. Oncotarget. 2015 Feb 20;6(5):2709-24. PMCID: PMC4413612
26. Ding X, Ma M, Teng J, Teng RK, Zhou S, Yin J, Fonkem E, Huang JH, Wu E, Wang X. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure. Oncotarget. 2015 Sep 15;6(27):24178-91. PMCID: PMC4695178
27. Fonkem E, Dayawansa S, Stroberg E, Lok E, Bricker PC, Kirmani B, Wong ET, Huang JH. Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients. BMC Neurol. 2016 Jan 16;16:9. PMCID: PMC4744383
28. Fonkem E, Dandashi JA, Stroberg E, Garrett D Jr, Harris FS, El Nihum IM, Cooper J, Dayawansa S, Huang JH. A retrospective analysis of meningioma in Central Texas. J Epidemiol Glob Health. 2016 Jun;6(2):87-93. PMCID: PMC7320443
29. Stroberg E, Uhrbrock DH, Harris F, Mutyala S, DiPatre PL, Fonkem E. Multiple dural-based hemangiopericytomas. Proc (Bayl Univ Med Cent). 2016 Apr;29(2):191-3. PMCID: PMC4790568
30. Kirmani BF, Robinson DM, Fonkem E, Graf K, Huang JH. Role of Anticonvulsants in the Management of Posttraumatic Epilepsy. Front Neurol. 2016;7:32. PMCID: PMC4801868
31. Dandashi JA, Nizamutdinov D, Dayawansa S, Fonkem E, Huang JH. Texas Occurrence of Lyme Disease and Its Neurological Manifestations. J Neuroinfect Dis. 2016 Jun;7(2). PMCID: PMC4962872
32. Nizamutdinov D, Patel NP, Huang JH, Fonkem E. Intravascular Lymphoma in the CNS: Options for Treatment. Curr Treat Options Neurol. 2017 Aug 23;19(10):35. PMCID: PMC5569665
33. Nizamutdinov D, Stock EM, Dandashi JA, Vasquez EA, Mao Y, Dayawansa S, Zhang J, Wu E, Fonkem E, Huang JH. Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma. World Neurosurg. 2018 Jan;109:e67-e74. PMCID: PMC5729086
34. Kirmani BF, Barr D, Robinson DM, Pranske Z, Fonkem E, Benge J, Huang JH, Ling G. Management of Autoimmune Status Epilepticus. Front Neurol. 2018;9:259. PMCID: PMC5954092
35. Ambe SN, Lyon KA, Nizamutdinov D, Fonkem E. Incidence trends, rates, and ethnic variations of primary CNS tumors in Texas from 1995 to 2013. Neurooncol Pract. 2018 Aug;5(3):154-160. PMCID: PMC6075522
36. Wang F, Zheng Z, Guan J, Qi D, Zhou S, Shen X, Wang F, Wenkert D, Kirmani B, Solouki T, Fonkem E, Wong ET, Huang JH, Wu E. Identification of a panel of genes as a prognostic biomarker for glioblastoma. EBioMedicine. 2018 Nov;37:68-77. PMCID: PMC6284420
37. Wang F, Zhou S, Qi D, Xiang SH, Wong ET, Wang X, Fonkem E, Hsieh TC, Yang J, Kirmani B, Shabb JB, Wu JM, Wu M, Huang JH, Yu WH, Wu E. Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells. J Am Chem Soc. 2019 Feb 27;141(8):3613-3622.
38. Lu G, Rao M, Zhu P, Liang B, El-Nazer RT, Fonkem E, Bhattacharjee MB, Zhu JJ. Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study. Front Neurol. 2019;10:42. PMCID: PMC6366009
39. Yari N, Benardete EA, Chen W, Ambe SN, Fonkem E. Outcomes with acyclovir treatment in herpes simplex encephalitis after surgery for solid CNS tumors: a case report and systematic review of the literature. Neurooncol Pract. 2019 Jul;6(4):259-263. PMCID: PMC6660819
40. Tadipatri R, Lyon K, Azadi A, Fonkem E. A view of the epidemiologic landscape: how population-based studies can lend novel insights regarding the pathophysiology of glioblastoma. Chin Clin Oncol. 2021 Aug;10(4):35.
41. Mukherjee S, Stroberg E, Wang F, Morales L, Shan Y, Rao A, Huang JH, Wu E, Fonkem E. SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM. J Neuropathol Exp Neurol. 2020 May 01;79(5):562-565. PMCID: PMC7160617
42. Umbach G, El Ahmadieh TY, Plitt AR, Aoun SG, Neeley OJ, Lyon KA, Fonkem E, Raisanen JM, Bishop JA, Wardak Z, Patel TR, Myers L, Mickey BE. Extraneural metastatic anaplastic ependymoma: a systematic review and a report of metastases to bilateral parotid glands. Neurooncol Pract. 2020 Mar;7(2):218-227. PMCID: PMC7318859
43. Howell SG, Lyon KA, Garrett D Jr, Huang JH, Fonkem E. Optimum treatment for primary intracranial Ewing sarcoma. Proc (Bayl Univ Med Cent). 2020 Jul;33(3):430-432. PMCID: PMC7340410
44. Nizamutdinov D, Dayawansa S, Fonkem E, Huang JH. Demographics of Astrocytoma in Central Texas: The Interaction Between Race, Histology, and Primary Tumor Site. Cureus. 2020 Aug 11;12(8):e9676. PMCID: PMC7486020
45. Ambe S, Nizamutdinov D, Huang JH, Fonkem E. Incidence of Primary Central Nervous System Tumors Among the Hispanic Population in Texas 1995-2013. Cureus. 2020 Sep 03;12(9):e10235. PMCID: PMC7535946
46. Ambe S, Lyon KA, Oh J, Rogers MKN, Olanipekun O, Basil NN, Fonkem E. Racial Disparities in Malignant Primary Brain Tumor Survival in Texas From 1995 to 2013. Cureus. 2020 Nov 25;12(11):e11710. PMCID: PMC7769829
47. Boccia ML, Anyanda EI, Fonkem E. A Preliminary Report on Quality of Life and Sexual Function in Brain Tumor Patients. J Sex Med. 2021 Apr;18(4):737-742.
48. Fonkem E, Peng S, Berens M, Mukherjee S. Authors' Reply: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM. J Neuropathol Exp Neurol. 2021 Feb 22;80(3):290-291.
49. Murillo J, Artz J, Brahmaroutu A, Gunnell S, Benge J, Lyon K, Fonkem E. An Exploratory Study of the Frequency of Central Nervous System Tumors by Type in the Central Texas Military and Civilian Populations. Cureus. 2021 Mar 14;13(3):e13885. PMCID: PMC8043054
50. Fonkem E, Gatson NTN, Tadipatri R, Cole S, Azadi A, Sanchez M, Stefanowicz E. Telemedicine review in neuro-oncology: comparative experiential analysis for Barrow Neurological Institute and Geisinger Health during the 2020 COVID-19 pandemic. Neurooncol Pract. 2021 Apr;8(2):109-116. PMCID: PMC7665592
51. Tadipatri R, Azadi A, Cowdrey M, Fongue SF, Smith P, Razis E, Boccia M, Ghouri Y, Zozzaro-Smith P, Fonkem E. Neuro-Oncology Palliative Care Survey of Physicians in Sub-Saharan Africa. J Pain Symptom Manage. 2021 Nov;62(5):1020-1025.
52. Gatson NTN, Makary M, Bross SP, Vadakara J, Maiers T, Mongelluzzo GJ, Leese EN, Brimley C, Fonkem E, Mahadevan A, Sarkar A, Panikkar R. Case series review of neuroradiologic changes associated with immune checkpoint inhibitor therapy. Neurooncol Pract. 2021 Jun;8(3):247-258. PMCID: PMC8153815
53. Mbi Feh MK, Lyon KA, Brahmaroutu AV, Tadipatri R, Fonkem E. The need for a central brain tumor registry in Africa: A review of central nervous system tumors in Africa from 1960 to 2017. Neurooncol Pract. 2021 Jun;8(3):337-344. PMCID: PMC8153807
54. Yuen KCJ, Mortensen MJ, Azadi A, Fonkem E, Findling JW. Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemic. Endocrinol Diabetes Metab. 2021 Jul;4(3):e00246. PMCID: PMC8250331
55. Chukwueke UN, Vera E, Acquaye A, Hervey-Jumper SL, Odia Y, Klesse LJ, Dunbar E, Sharma A, Fonkem E, Thomas AA, Werbowetski-Ogilvie TE, Camelo-Piragua S, Gatson NTN, de la Fuente MI, Armstrong TS, Porter AB, Jackson S. SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology. Neuro Oncol. 2021 Nov 02;23(11):1845-1858. PMCID: PMC8563326
56. Gatson NTN, Boccia ML, Taylor KR, Mack JKO, Fonkem E. Hormone-Dependent Tumors and Sexuality in the Neuro-Oncology of Women (N.O.W.): Women's Brain Tumors, Gaps in Sexuality Considerations, and a Need for Evidence-Based Guidelines. Curr Oncol Rep. 2021 Aug 27;23(11):127.
57. Tadipatri R, Gonzalez D, Muley S, Fonkem E, Azadi A. A Rare Case of Burkitt's Lymphoma Presenting With Features Mimicking Vogt-Koyanagi-Harada Disease. Cureus. 2021 Sep;13(9):e17659. PMCID: PMC8487221
58. Ekhator C, Kesari S, Tadipatri R, Fonkem E, Grewal J. The Emergence of Virtual Tumor Boards in Neuro-Oncology: Opportunities and Challenges. Cureus. 2022 Jun;14(6):e25682. PMCID: PMC9169580
59. Smith KA, Hendricks BK, DiDomenico JD, Conway BN, Smith TL, Azadi A, Fonkem E. Ketogenic Metabolic Therapy for Glioma. Cureus. 2022 Jun;14(6):e26457. PMCID: PMC9339381
60. Ekhator C, Rak R, Tadipatri R, Fonkem E, Grewal J. A Single-Center Experience of Dopamine Antagonist ONC201 for Recurrent Histone H3 Lysine 27-to-Methionine (H3K27M)-Mutant Glioblastoma in Adults. Cureus. 2022 Aug;14(8):e28175. PMCID: PMC9482800
61. Ekhator C, Nwankwo I, Rak E, Homayoonfar A, Fonkem E, Rak R. GammaTile: Comprehensive Review of a Novel Radioactive Intraoperative Seed-Loading Device for the Treatment of Brain Tumors. Cureus. 2022 Oct;14(10):e29970. PMCID: PMC9541893
62. Basil NN, Ambe S, Ekhator C, Fonkem E. Health Records Database and Inherent Security Concerns: A Review of the Literature. Cureus. 2022 Oct;14(10):e30168. PMCID: PMC9647912
63. Nduma BN, Ambe S, Ekhator C, Fonkem E. Geographical Distribution of Pancreatic Cancer in the State of Mississippi by Incidence and Mortality From 2003 to 2019. Cureus. 2022 Nov;14(11):e31605. PMCID: PMC9671138
64. Nduma BN, Ambe S, Ekhator C, Fonkem E. Falling Trend in the Epidemiology of Gastric Cancer in Mississippi From 2003 to 2019: What Mississippi Got Right. Cureus. 2022 Nov;14(11):e31440. PMCID: PMC9658492
65. Qi D, Li J, Quarles CC, Fonkem E, Wu E. Assessment and prediction of glioblastoma therapy response: challenges and opportunities. Brain. 2023 Apr 19;146(4):1281-1298. PMCID: PMC10319779
66. Tadipatri R, Eschbacher J, Fonkem E, Kresl J, Azadi A. Larotrectinib in NTRK Fusion-Positive High-Grade Glioneuronal Tumor: A Case Report. Cureus. 2022 Nov;14(11):e31449. PMCID: PMC9747057
67. Kelly RJ, Whitsett TG, Snipes GJ, Dobin SM, Finholt J, Settele N, Priest EL, Youens K, Wallace LB, Schwartz G, Wong L, Henderson SM, Gowan AC, Fonkem E, Juarez MI, Murray CE, Wu J, Van Keuren-Jensen K, Pirrotte P, Highlander S, Contente T, Baker A, Victorino J, Berens ME. The Texas Immuno-Oncology Biorepository, a statewide biospecimen collection and clinical informatics system to enable longitudinal tumor and immune profiling. Proc (Bayl Univ Med Cent). 2023;36(1):1-7. PMCID: PMC9762845
68. Qi D, Geng Y, Cardenas J, Gu J, Yi SS, Huang JH, Fonkem E, Wu E. Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers. NPJ Genom Med. 2023 Jan 25;8(1):2. PMCID: PMC9877004
69. Armitage AE, Fonkem E. Supportive care of neurodegenerative patients. Front Oncol. 2023;13:1029938. PMCID: PMC9974138
70. Ekhator C, Urbi A, Nduma BN, Ambe S, Fonkem E. Safety and Efficacy of Radiofrequency Ablation and Epidural Steroid Injection for Management of Cervicogenic Headaches and Neck Pain: Meta-Analysis and Literature Review. Cureus. 2023 Feb;15(2):e34932. PMCID: PMC10016315
71. Tadipatri R, Ekhator C, Narayan R, Azadi A, Yuen KCJ, Grewal J, Fonkem E. Iatrogenic immunodeficiency-associated lymphoproliferative disorders of the central nervous system: a treatment paradox. Neurooncol Pract. 2023 Apr;10(2):169-175. PMCID: PMC10037938
72. Nduma BN, Mofor KA, Tatang J, Ekhator C, Ambe S, Fonkem E. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature. Cureus. 2023 Mar;15(3):e36148. PMCID: PMC10101654
73. Nduma BN, Mofor KA, Tatang JT, Ekhator C, Ambe S, Fonkem E. Endoscopic Gastric Sleeve: A Review of Literature. Cureus. 2023 Mar;15(3):e36353. PMCID: PMC10112045
74. Barkhoudarian G, Badruddoja M, Blondin N, Chowdhary S, Cobbs C, Duic JP, Flores JP, Fonkem E, McClay E, Nabors LB, Salacz M, Taylor L, Vaillant B, Gill J, Kesari S. An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma. CNS Oncol. 2023 Sep 01;12(3):CNS102. PMCID: PMC10410686
75. Nduma B, Ambe S, Ekhator C, Fonkem E. Gender and racial disparities in the incidence and mortality of pancreatic cancer in Mississippi State from 2003 to 2019. J Gastrointest Oncol. 2023 Jun 30;14(3):1478-1487. PMCID: PMC10331749

Books, Chapters, and Reviews
1. Shan, Frank & Zhao, Dachun & Tirado, Carlos & Fonkem, Ekokobe & Zhang, Yi-lu & Feng, Dong-xia & Huang, Jason. (2022). Glioblastomas: Molecular Diagnosis and Pathology. In book: Glioblastoma - Current Evidences. Submitted: May 10th, 2022 Reviewed: May 19th, 2022 Published: July 8th, 2022. DOI: 10.5772/intechopen.105472.
2. Shan FY, Zhong D, Hu W, Patel N, Fonkem E, Feng D, Zhang Y, Huang JH and Rao A. “Neoplasm of Central Nervous System: A Diagnostic Approach”. In book: Neoplasm. Reviewed: March 7th, 2018 Published: November 5th, 2018. DOI: 10.5772/intechopen.76294. https://www.intechopen.com/books/neoplasm/neoplasms-of-central-nervous-system-a-diagnostic-approach.
3. Frank Y. Shan, E. Castro, Amelia Sybenga, Sanjib Mukherjee,Erxi Wu, Karming Fung, The Li, Ekokobe Fonkem,Jason H. Huang and A. Rao “Molecular Diagnostics and Pathology of Major Brain Tumors”. In book: Primary Intracranial Tumors. Submitted: June 28th, 2018 Reviewed: August 10th, 2018 Published: December 31st, 2018. DOI: 10.5772/intechopen.80856. https://www.intechopen.com/online-first/molecular-diagnostics-and-pathology-of-major-brain-tumor.
4. Ekokobe Fonkem and Ramaya Tadipatri, “Treatment Devices in Neuro-Oncology”. Neuro-Oncology Compendium for the Boards and Clinical Practice. Oxford University Press (Reference Textbook). [in contract 2019, publication date 03/2021]. ISBN: 9780197573778
5. Nizamutdinov D, Dandashi JA, Stock EM, Kirmani BF, Stroberg E, Wu E, Dayawansa S, Huang JH, Fonkem E. “Ependymomas: Prognostication, Treatment Strategies, and Clinical Outcomes in Ependymoma Diagnosed Patients”. Nova Science Publishers, INC. Cancer Etiology, Diagnosis and Treatments. 2016. ISBN: 978-1-63484-420-8
6. Fonkem E. et al. Co-author in Book Chapter. Osteopathic Medicine Recall, Lippincott, Williams & Wilkins. 2007. 200 pages. IP: 10.75.204.27. http://ebookbrowse.in/pdf/title/recall-medicine.html
7. Newton HB, Fonkem E, Tadipatri R. “Overview of Brain Tumor Epidemiology.” Handbook of Neuro-Oncology Neuroimaging (Third Edition). Book Chapter. 2022. ISBN: 9780128228357
8. Newton HB, Fonkem E, Tadipatri R. “Overview of Pathology and Treatment of Primary Brain Tumors.” Handbook of Neuro-Oncology Neuroimaging (Third Edition). Book Chapter. 2022. ISBN: 9780128228357
9. Newton HB, Fonkem E, Tadipatri R. “Overview of Pathology and Treatment of Metastatic Brain Tumors.” Handbook of Neuro-Oncology Neuroimaging (Third Edition). Book Chapter. 2022. ISBN: 9780128228357
10. Newton HB, Fonkem E, Tadipatri R. “Overview of Spinal Cord Tumor Epidemiology.” Handbook of Neuro-Oncology Neuroimaging (Third Edition). Book Chapter. 2022. ISBN: 9780128228357
11. Newton HB, Fonkem E, Tadipatri R. “Overview of Pathology and Treatment of Primary Spinal Cord Tumors.” Handbook of Neuro-Oncology Neuroimaging (Third Edition). Book Chapter. 2022. ISBN: 9780128228357
12. Newton HB, Fonkem E, Tadipatri R. “Overview of Pathology and Treatment of Intramedullary Spinal Cord Metastases.” Handbook of Neuro-Oncology Neuroimaging (Third Edition). Book Chapter. 2022. ISBN: 9780128228357
13. Ekokobe Fonkem, Amir Azadi, Ramya Tadipatri. “Device-Based Treatments in Neuro-Oncology”. In book: Neuro-Oncology Compendium for the Boards and Clinical Practice. July 2023. DOI: 10.1093/med/9780197573778.003.0022.
14. Congxin Dai, Xiaohai Liu, Sihai Ma, Ming Feng, Xinjie Bao, Kan Deng, Yong Yao, Renzhi Wang, DX. Feng, E. Fonkem, Frank Y. Shan and Jason H. Huang. Management of Refractory/Aggressive Pituitary. Adenomas Review of Current Treatment Options. In book: Primary Intracranial Tumors. Submitted: September 6th, 2018, Reviewed: September 11th, 2018 Published: December 31st, 2018. DOI: 10.5772/intechopen.81464.

Non-Refereed Journal Publications/Original Papers
1. Dr. Ekokobe Fonkem and the Neuro-Oncology Team. Neuro-Oncology Newsletter \| Spring 2021 Issue. Barrow Neurologivcal Institite. https://www.barrowneuro.org/wp-content/uploads/NeuroOncology_News_3-21.pdf.
2. Kristopher Lyon, MD and Ekokobe Fonkem, DO “Spinal Astrocytoma” Medlink Neurology, July, 23, 2019.

Abstracts
1. Ramamurthy, Bhaskar & Keralapura, Mallika & Marshall, Jack & Need, Dan & Dittamore, Ryan & Kesari, Santosh & Fonkem, Ekokobe. (2022). Abstract 386: Non-intrusive, non-invasive and patient friendly focused ultrasound device as a delivery vehicle for CNS tumors. Cancer Research. 82. 386-386. 10.1158/1538-7445.AM2022-386.
2. Fonkem, Ekokobe & Rogers, M. & Tobin, Richard & Healey, Deborah & Das, Mita & Bowen, Sara & Quarles, Chad & Clark, John. (2022). Abstract LB136: Characterization of a novel PI3Kinase inhibitor for treatment of glioblastoma multiforme. Cancer Research. 82. LB136-LB136. 10.1158/1538-7445.AM2022-LB136.
3. Sonikpreet Aulakh, Joanne Xiu, Pavel Brodskiy, Ekokobe Fonkem, Sourat Darabi, Michael J. Demeure, Soma Sengupta, Santosh Kesari, David M. Ashley, Ashley Love Sumrall, Michael J. Glantz, David Spetzler. Biological and prognostic relevance of epigenetic regulatory genes in high-grade gliomas (HGGs). Meeting Abstract \| 2022 ASCO Annual Meeting I. Journal of Clinical Oncology, Volume 40, 40. 2019-2019. 10.1200/JCO.2022.40.16_suppl.2019.
4. Berens, Michael & Peng, Sen & Lee, Matthew & Tang, Nanyun & Ahluwalia, Manmeet & Fonkem, Ekokobe & Fink, Karen & Raizer, Jeffrey & Walker, Christopher & Dhruv, Harshil. (2022). Abstract 4102: Vulnerability signature guided glioblastoma umbrella trial. Cancer Research. 82. 4102-4102. 10.1158/1538-7445.AM2022-4102.
5. Lee, Matthew & Tang, Nanyun & Ahluwalia, Manmeet & Fonkem, Ekokobe & Fink, Karen & Dhruv, Harshil & Berens, Michael & Peng, Sen. (2021). Abstract 180: Identifying signatures of vulnerability through machine learning in an umbrella trial for glioblastoma. Cancer Research. 81. 180-180. 10.1158/1538-7445.AM2021-180.
6. Margaret O Johnson, Joanne Xiu, Michael J Glantz, Ekokobe Fonkem, David M. Ashley. The Mutational Landscape of older Patients with IDH wide type- glioblastoma (GBM). May 2021. Journal of Clinical Oncology. 39(15_supp) e14033.
7. Matthew Lee, Nanyun Tang, Manmeet Ahluwalia, Ekokobe Fonkem, Karen Fink, Harshil Dhruv, Michael Berens, and Sen Peng. BIOM-24. IDENTIFYING VULNERABILITY SIGNATURES THROUGH MACHINE LEARNING IN AN UMBRELLA TRIAL FOR GLIOBLASTOMA. Neuro Oncol. 2020 Nov; 22(Suppl 2): ii6–ii7. Published online 2020 Nov 9. doi: 10.1093/neuonc/noaa215.024. PMCID: PMC7650318.
8. Amir Azadi, Ekokobe Fonkem, and Tejas Ranade. EPID-12. TREATMENT OUTCOMES OF MIDLINE GLIOMAS WITH H3K27 M: OUR BARROW NEUROLOGICAL INSTITUTE EXPERIENCE. Neuro Oncol. 2020 Nov; 22(Suppl 2): ii81. Published online 2020 Nov 9. doi: 10.1093/neuonc/noaa215.330. PMCID: PMC7651577.
9. Marilyn Mbi Feh, Ankita Brahmaroutu, Kristopher Lyon, and Ekokobe Fonkem. EPID-23. A SYSTEMIC REVIEW OF CENTRAL NERVOUS SYSTEM TUMORS IN AFRICA FROM 1960 – 2017 AND THE NEED FOR A CENTRAL BRAIN TUMOR REGISTRY IN AFRICA. Neuro Oncol. 2020 Nov; 22(Suppl 2): ii83. Published online 2020 Nov 9. doi: 10.1093/neuonc/noaa215.341. PMCID: PMC7651093
10. Ramya Tadipatri, Amir Azadi, Madison Cowdrey, Samuel Fongue, Paul Smith, Evangelia Razis, Maria Boccia, and Ekokobe Fonkem. QOLP-03. NEURO-ONCOLOGY PALLIATIVE CARE SURVEY OF PHYSICIANS IN SUB-SAHARAN AFRICA. Neuro Oncol. 2020 Nov; 22(Suppl 2): ii175. Published online 2020 Nov 9. doi: 10.1093/neuonc/noaa215.728. PMCID: PMC7651044.
11. Qi, Dan & Wang, Fengfei & Fonkem, Ekokobe & Huang, Jason & Wu, Erxi. (2019). Abstract 1122: CD44 as potential therapeutic target for medulloblastoma metastasis. Cancer Research. 79. 1122-1122. 10.1158/1538-7445.AM2019-1122.
12. Olafsen LJ, Jones B, Sparks L, Nguyen HH, Tanner A, Schubert KE, Olafsen JS, Dayawansa S, Fonkem E, Huang JH. Current-Controlled Nitinol Wire for Improved Arterial Navigation. 2019. Submitted to SPIE Biomedical Optics. Proceedings Volume 10868, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XVII; 108681E (2019) https://doi.org/10.1117/12.2511670. Event: SPIE BiOS, 2019, San Francisco, California, United States. 26 February 2019.
13. Nizamutdinov D, Dandashi JA, Stock EM, Kirmani BF, Stroberg E, Wu E, Dayawansa S, Huang JH, Fonkem E. A Retrospective Study to Explore Prognostic Factors for Ependymoma Survival. Clinics in Oncology. 2016.
14. Lateef Odukoya, Thomas Kollmeyer, Jeanette Eckel-Passow, Cristiane Ida, Daniel Lachance, Ekokobe Fonkem, Kabir Badmos, Olufemi Bankole, Gaspar Kitange, Adetola Daramola, Charles Anunobi, Robert Jenkins. Histopathologic and molecular profile of gliomas: a 9-year retrospective study of cases diagnosed in Lagos Nigeria. Society of Neuro-Oncology of Sub-Saharan Africa (SNOSSA) 5th Annual Meeting, Nairobi, Kenya. July 20-22, 2023.
15. Ramya Tadipatri, Ekokobe Fonkem. A Comparative Analysis of Brain Tumor Palliative Care Practices in Cameroon and Nigeria. Society of Neuro-Oncology of Sub-Saharan Africa (SNOSSA) 5th Annual Meeting, Nairobi, Kenya. July 20-22, 2023.
16. Lateef Odukoya, David Kamson, Jeanette Eckel-Passow, Nathalie Ghomsi, Robert Jenkins, James Balogun, Daniel Lachance, Claire Karekezi, Chukwuyem Ekhator, Lawrence Osei-Tutu, Advera Ngaiza, Liadi Tiamiyu, Angela Mwakimonga, Jason Huse, Arsene Nyalundja, Teddy Totimeh, Kabir Badmos, Olufemi Bankole, Gaspar Kitange, Desmond Brown, Charles Anunobi, Kristin Schroeder, Ekokobe Fonkem, Beverly Cheserem, Francis Zerd. Feasibility Study on brain tumor biobanking and registry in sub-Saharan African Countries: a questionnaire-based survey. Society of Neuro-Oncology of Sub-Saharan Africa (SNOSSA) 5th Annual Meeting, Nairobi, Kenya. July 20-22, 2023.
17. Ekokobe Fonkem, Francis Fezeu, Mounir Bennis Fotso, Vincent Djientcheu, Yaya Besong, Colton Betts. A retrospective study of brain tumours in Yaounde Cameroon. Society of Neuro-Oncology of Sub-Saharan Africa (SNOSSA) 5th Annual Meeting, Nairobi, Kenya. July 20-22, 2023.
18. Fengfei Wang, Xin Shen, XJessica Pruszynski, Jason Huang, Batool Kirmani, Erxi Wu, Ekokobe Fonkem. Abstract 465: CD44 as a potential therapeutic target and prognosis marker for glioblastoma. July 2016, Cancer Research 76(14 Supplement):465-465Follow journal. DOI: 10.1158/1538-7445.AM2016-465.
19. Shuang Zhou, Fengfei Wang, Shi-hua Xiang, Eric T. Wong, Wallace W. Muhonen, Ekokobe Fonkem, Tze-Chen Hsieh, David Li, Ruiwen Zhang, John B. Shabb, Joseph Wu, Min Wu, Erxi Wu. Abstract 4614: Identification of two salinomycin binding targets in neuroblastoma. October 2014Cancer Research 74(19 Supplement):4614-4614Follow journal. DOI: 10.1158/1538-7445.AM2014-4614
20. Margaret Johnson, April Bell, Yajas Shah, Kayla Viets-Layng, Elizabeth Mauer, Joanne Xiu, Olivier Elemento, Michael Glantz, Phillip Walker, Clark Chen, Erin Dunbar, Ekokobe Fonkem, Santosh Kesari, Andrew Brenner, Herbert Newton, Justin Low, Ashley Sumrall, Wolfgang Korn, David Ashley, Derek Wainwright. BIOM-43. THE GENOMIC, TRANSCRIPTOMIC, AND EPIGENOMIC LANDSCAPE OF ISOC Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii13–vii14, https://doi.org/10.1093/neuonc/noac209.053. Published: 14 November 2022.
21. Ramya Tadipatri, Chukwuyem Ekhator, Adela Miller, Jai Grewal, Manmeet Ahluwalia, Ekokobe Fonkem. CSIG-06. RETROSPECTIVE REVIEW OF GLIOMA PATIENTS WITH CONFIRMED MET AMPLIFICATION OR FUSION. Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii39, https://doi.org/10.1093/neuonc/noac209.155. Published: 14 November 2022.
22. Chukwuyem Ekhator, Ramin Rak, Ramya Tadipatri, Ekokobe Fonkem, Jai Grewal. CTNI-24. SINGLE CENTER EXPERIENCE OF DOPAMINE ANTAGONIST ONC-201 FOR RECURRENT H3K27M-MUTANT GLIOBLASTOMA IN ADULTS. Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii75–vii76, https://doi.org/10.1093/neuonc/noac209.289. Published: 14 November 2022
23. Ramya Tadipatri, Chukwuyem Ekhator, Ram Narayan, Amir Azadi, Kevin Yuen, Jai Grewal, Ekokobe Fonkem. EPID-18. IATROGENIC IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS OF THE CENTRAL NERVOUS SYSTEM: A TREATMENT PARADOX. Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii113, https://doi.org/10.1093/neuonc/noac209.428. Published: 14 November 2022
24. Chukwuyem Ekhator, Ramin Rak, Ramya Tadipatri, Ekokobe Fonkem, Jai Grewal. QLTI-23. BRAIN TUMOR-RELATED PAIN: INNOVATIVE APPROACHES TO DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE ISSUES: A SYSTEMATIC REVIEW AND META-ANALYSIS. Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii239, https://doi.org/10.1093/neuonc/noac209.925. Published: 14 November 2022.
25. Ekokobe Fonkem, Karen newell Rogers, Richard Tobin, Mita Das, Sara Bowen, Ramya Tadipatri, Debbie Healey, Christopher Quarles, John Clark. DDEL-08. NOVEL COMBINATION THERAPY USING PI3KINASE INHIBITION AND IMMUNE BASED THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME. Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii95, https://doi.org/10.1093/neuonc/noac209.354. Published: 14 November 2022.
26. Chukwuyem Ekhator, Santosh Kesari, Ramya Tadipatri, Ekokobe Fonkem, Jai Grewal. INNV-26. EMERGENCE OF VIRTUAL TUMOR BOARD [VTB] IN NEURO-ONCOLOGY: OPPORTUNITIES AND CHALLENGES. Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii147, https://doi.org/10.1093/neuonc/noac209.566. Published: 14 November 2022
27. F Fezeu, C Opara, V Djientcheu, E Fonkem, S Samnick. P13.01.A Challenges and Solutions for Establishing a CNS Tumor Registry in Africa. Neuro-Oncology, Volume 24, Issue Supplement_2, September 2022, Page ii80, https://doi.org/10.1093/neuonc/noac174.281. Published: 05 September 2022.
28. Chukwuyem Ekhator, Santosh Kesari, Ramya Tadipatri, Ekokobe Fonkem, Jai Grewal. CLRM-01 SUMMARY OF VIRTUAL TUMOR BOARD PLATFORMS AND IMPLEMENTATION IN NEURO-ONCOLOGY. Neuro-Oncology Advances, Volume 4, Issue Supplement_1, August 2022, Page i6, https://doi.org/10.1093/noajnl/vdac078.022. Published: 05 August 2022
29. Chukwuyem Ekhator, Ramin Rak, Ramya Tadipatri, Ekokobe Fonkem, Jai Grewal. CLRM-02 SINGLE CENTER EXPERIENCE OF DOPAMINE ANTAGONIST ONC-201 FOR RECURRENT H3K27M-MUTANT GLIOBLASTOMA IN ADULTS. Neuro-Oncology Advances, Volume 4, Issue Supplement_1, August 2022, Page i6, https://doi.org/10.1093/noajnl/vdac078.023. Published: 05 August 2022.
30. Ramya Tadipatri, Chukwuyem Ekhator, Ram Narayan, Amir Azadi, Kevin C.J. Yuen, Jai Grewal, Ekokobe Fonkem. Comprehensive analysis of non-transplant central nervous system lymphoproliferative disease associated with immunosuppressant use. Meeting Abstract \| 2022 ASCO Annual Meeting I. CENTRAL NERVOUS SYSTEM TUMORS. Journal of Clinical Oncology; List of Issues; Volume 40, Issue 16_suppl.
31. Chukwuyem Ekhator, Santosh Kesari, Ramya Tadipatri, Ekokobe Fonkem, Jai Grewal. Summary of virtual tumor board platforms and implementation in neuro-oncology. Meeting Abstract \| 2022 ASCO Annual Meeting I. CARE DELIVERY AND REGULATORY POLICY. Journal of Clinical Oncology. List of Issues. Volume 40, Issue 16_suppl.
32. Sen Peng, Matthew Lee, Nanyun Tang, Manmeet Ahluwalia, Ekokobe Fonkem, Karen Fink, Jeffrey Raizer, Christopher Walker, Harshil Dhruv, Michael Berens. RTID-08. MACHINE LEARNING TO UNCOVER SIGNATURES OF VULNERABILITY IN GLIOBLASTOMA UMBRELLA SIGNATURE TRIAL (GUST). Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi194, https://doi.org/10.1093/neuonc/noab196.770. Published: 12 November 2021.
33. Timothy Stuhlmiller, Mark Shapiro, Asher Wasserman, Zachary Osking, Jeff Shrager, Bryan Federowicz, Matthew Warner, Julie Friedland, Al Musella, Nicholas Blondin, Ekokobe Fonkem, Eric Wong, Santosh Kesari. INNV-37. XCELSIOR: A REAL-TIME, REAL-WORLD LEARNING PLATFORM FOR PATIENTS WITH ADVANCED CANCER. Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi113, https://doi.org/10.1093/neuonc/noab196.448. Published: 12 November 2021.
34. Ugonma Chukwueke, Elizabeth Vera, Alvina Acquaye, Shawn Hervey-Jumper, Yazmin Odia, Laura Klesse, Erin Dunbar, Akanksha Sharma, Ekokobe Fonkem, Alissa Thomas, Tamra Werbowetski-Ogilvie, Sandra Camelo-Piragua, Na Tosha Gatson, Macarena de la Fuente, Terri Armstrong, Alyx Porter, Sadhana Jackson. OTHR-01. SNO 2020 DIVERSITY SURVEY: DEFINING DEMOGRAPHICS, RACIAL BIASES, CAREER SUCCESS METRICS AND A PATH FORWARD FOR THE FIELD OF NEURO-ONCOLOGY. Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi151, https://doi.org/10.1093/neuonc/noab196.593. Published: 12 November 2021.
35. Bhaskar Ramamurthy, Mallika Keralapura, John Marshall, Daniel Need, Ryan Dittamore, Santosh Kesari, Ekokobe Fonkem. INNV-36. NON-INTRUSIVE, NON-INVASIVE AND PATIENT FRIENDLY FOCUSED ULTRASOUND DEVICE AS A DELIVERY VEHICLE FOR CNS TUMORS. Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi113, https://doi.org/10.1093/neuonc/noab196.447. Published: 12 November 2021.
36. Ramya Tadipatri, Dinko Plasto, Jeremy Hughes, Peter Nakaji, Jennifer Eschbacher, Ekokobe Fonkem, Amir Azadi, Kelly Braun, Charlotte Myers, Lynn Ashby. NIMG-57. MANAGEMENT OF TECTAL GLIOMAS IN ADULTS. Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi142, https://doi.org/10.1093/neuonc/noab196.555. Published: 12 November 2021.
37. Sen Peng, Matthew Lee, Nanyun Tang, Manmeet Ahluwalia, Ekokobe Fonkem, Karen Fink, Jeffrey Raizer, Christopher Walker, Harshil Dhruv, Michael Berens. CLRM-01. MACHINE LEARNING TO UNCOVER SIGNATURES OF VULNERABILITY IN GLIOBLASTOMA UMBRELLA SIGNATURE TRIAL (GUST). Neuro-Oncology Advances, Volume 3, Issue Supplement_4, October 2021, Page iv1, https://doi.org/10.1093/noajnl/vdab112.000. Published: 21 September 2021.
38. Kyle Walsh, Joanne Xiu, Giselle López, Daniel Landi, Zachary Reitman, Sandeep Mittal, Andrew Brenner, Ekokobe Fonkem, Santosh Kesari, Surasak Phuphanich, Herbert Newton, Manjari Pandey, Emil Lou, Michael Glantz, Ashley Sumrall, Erin Dunbar, Macarena De La Fuente, W Michael Korn, Mustafa Khasraw, David Ashley. BIOM-17. BRAF MUTATION IS AN EARLY EVENT IN THE EVOLUTION OF A SUBSET OF GLIOBLASTOMAS AND IS ASSOCIATED WITH INCREASED PD-L1 EXPRESSION. Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii5, https://doi.org/10.1093/neuonc/noaa215.017. Published: 09 November 2020.
39. Ekokobe Fonkem, Na Tosha Gatson, Ramya Tadipatri, Amir Azadi. COVD-14. TELEMEDICINE REVIEW IN NEURO-ONCOLOGY: COMPARATIVE EXPERIENTIAL ANALYSIS FOR BARROW NEUROLOGICAL INSTITUTE AND GEISINGER HEALTH DURING THE 2020 COVID-19 PANDEMIC. Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii23, https://doi.org/10.1093/neuonc/noaa215.097. Published: 09 November 2020.
40. Maria Boccia, Elizabeth Anyanda, Ekokobe Fonkem. QOLP-21. A PRELIMINARY REPORT ON QUALITY OF LIFE AND SEXUAL FUNCTION IN BRAIN CANCER PATIENTS. Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii179, https://doi.org/10.1093/neuonc/noaa215.746. Published: 09 November 2020.
41. M. Boccia, D. Levacic, E. Anyanda, E. Fonkem. 002 Sexual Dysfunction in Relation to Tumor Type, Location, and Treatment in Brain Cancer Patients Get access Arrow. The Journal of Sexual Medicine, Volume 17, Issue Supplement_3, July 2020, Page S219, https://doi.org/10.1016/j.jsxm.2020.04.238. Published: 01 July 2020.
42. Joanne Xiu, Kyle M Walsh, Manjari Pandey, Emil Lou, Ekokobe Fonkem, Herbert B. Newton, Erin M. Dunbar, Macarena Ines De La Fuente, Michael J. Glantz, Sandeep Mittal, David M. Ashley, Wolfgang Michael Korn, Ashley Love Sumrall. Molecular features of gliomas with high tumor mutational burden. Meeting Abstract \| 2020 ASCO Annual Meeting I. CENTRAL NERVOUS SYSTEM TUMORS. Journal of Clinical Oncology; List of Issues; Volume 38, Issue 15_suppl.
43. Garni Barkhoudarian, Nicholas Blondin, Sajeel Chowdhary, Ekokobe Fonkem, Brian Vaillant, Santosh Kesari. ACTR-69. FEASIBILITY STUDY OF THE EMULATE THERAPEUTICS™ VOYAGER SYSTEM IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi29, https://doi.org/10.1093/neuonc/noz175.110. Published: 11 November 2019.
44. Jennifer Murillo, Ankita Brahmaroutu, Wencong Chen, Jared Benge, Ekokobe Fonkem. EPID-08. TYPES OF BRAIN CANCER IN THE CENTRAL TEXAS MILITARY POPULATION. Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi76, https://doi.org/10.1093/neuonc/noz175.308. Published: 11 November 2019.
45. Solomon Ambe, Niloofar Yari, Ekokobe Fonkem, Ethan Benardete, Wencong Chen. NCMP-10. OUTCOMES WITH ACYCLOVIR TREATMENT IN HERPES SIMPLEX ENCEPHALITIS AFTER SURGERY FOR SOLID CNS TUMORS: A CASE REPORT AND SYSTEMATIC REVIEW OF THE LITERATURE. Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi181, https://doi.org/10.1093/neuonc/noz175.756. Published: 11 November 2019.
46. Macarena I De la Fuente, Howard Colman, Mark Rosenthal, Brian A Van Tine, Ekokobe Fonkem, Tobias Walbert, Mohammed Milhem, Kate Lipford, Sanjeev Forsyth, Sylvie Guichard, Julie Brevard, Yelena Mikhailov, Blythe Thomson, Varun Monga. ACTR-52. PHASE 1 STUDY OF FT-2102, AN INHIBITOR OF MUTANT IDH1, IN PATIENTS WITH RELAPSED/REFRACTORY IDH1 MUTANT GLIOMAS: PRELIMINARY SAFETY AND CLINICAL ACTIVITY. Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi25, https://doi.org/10.1093/neuonc/noz175.094. Published: 11 November 2019.
47. Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Ricky Chen, Sajeel Chowdhary, Charles Cobbs, Anthony Dowling, Paul Duic, John Paul Flores, Ekokobe Fonkem, Edward McClay, Louis Nabors, Michael Salacz, Brian Vaillant, Santosh Kesari. ACTR-68. FEASIBILITY STUDY OF THE EMULATE THERAPEUTICS™ VOYAGER SYSTEM IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM). Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi29, https://doi.org/10.1093/neuonc/noz175.109. Published: 11 November 2019.
48. Akhilesh Padhye, Ekokobe Fonkem, Wencong Chen. RARE-31. NATURAL HISTORY OF T-CELL CNS LYMPHOMA. Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi242, https://doi.org/10.1093/neuonc/noy148.1002. Published: 05 November 2018.
49. Akhilesh Padhye, Dong-Ho Gwak, Ekokobe Fonkem. HOUT-26. SURVIVAL OUTCOMES IN GLIOBLASTOMA PATIENTS USING TTFIELDS: THE BAYLOR SCOTT & WHITE MEDICAL CENTER IN CENTRAL TEXAS EXPERIENCE. Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi118–vi119, https://doi.org/10.1093/neuonc/noy148.494. Published: 05 November 2018.
50. Solomon Ambe, Olalekan Olanipekun, Ekokobe Fonkem. EPID-03. THE MINORITY ADVANTAGE -DISPARITIES IN PRIMARY BRAIN TUMOR SURVIVAL IN TEXAS STATE 1995–2013. Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi80, https://doi.org/10.1093/neuonc/noy148.330. Published: 05 November 2018.
51. Damir Nizamutdinov, Ekokobe Fonkem. EPID-03. INCIDENCE OF PRIMARY BRAIN AND CENTRAL NERVOUS SYSTEM TUMORS AMONG HISPANIC POPULATION IN TEXAS 1995–2013. Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi69, https://doi.org/10.1093/neuonc/nox168.281. Published: 06 November 2017.
52. Damir Nizamutdinov, Jad Dandashi, Eileen Stock, Samantha Dayawansa, Batool Kirmani, Erxi Wu, Jason Huang, Ekokobe Fonkem. EPID-17. DEMOGRAPHIC AND PRIMARY TUMOR LOCATION PROGNOSTIC FACTORS IN GLIOBLASTOMA SURVIVAL. Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi59, https://doi.org/10.1093/neuonc/now212.243. Published: 07 November 2016.
53. Damir Nizamutdinov, Jad Dandashi, Eileen Stock, Samantha Dayawansa, Jun Zhang, Ekokobe Fonkem, Erxi Wu, Jason Huang. EPID-18. DEMOGRAPHICAL PRESENTATION AND SURVIVAL OUTCOME OF ASTROCYTOMA IN CENTRAL TEXAS. Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi59, https://doi.org/10.1093/neuonc/now212.244. Published: 07 November 2016.
54. Kevin Graf, Ramiro Mancilla, Edana Stroberg, Samantha Dayawansa, Jason Huang, Ekokobe Fonkem. EPID-15: FAMILIAL PREDISPOSITION TO HIGH GRADE ASTROCYTOMA. Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v81, https://doi.org/10.1093/neuonc/nov213.15. Published: 09 November 2015.
55. Sanjib Mukherjee, Long Dao, Richard Tobin, Giuseppina Dusio, Ekokobe Fonkem, M. Karen Newell-Rogers. TMOD-07 * DIFFERENCES IN TUMOR GRAFT ACCEPTANCE OF 261 GLIOBLASTOMA MULTITFORME (GBM) CELL LINE BETWEEN WILD TYPE C57BL6, CD74 DEFICIENT, AND GAMMA DELTA TCR DEFICIENT MICE. Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v227, https://doi.org/10.1093/neuonc/nov237.07. Published: 09 November 2015.
56. Fengfei Wang; Marc Remke; Kruttika Bhat; Eric Wong; Shuang Zhou; Vijay Ramaswamy; Adrian Dubuc; Ekokobe Fonkem; Saeed Salem; Hongbing Zhang; Tze-chen Hsieh; Stephen O'Rourke; Lizi Wu; David Li; Cynthia Hawkins; Isaac Kohane; Joseph Wu; Min Wu; Michael Taylor; Erxi Wu. Abstract 3551: A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma. POSTER PRESENTATIONS - PROFFERED ABSTRACTS\| AUGUST 01 2015. Cancer Res (2015) 75 (15_Supplement): 3551. https://doi.org/10.1158/1538-7445.AM2015-3551.
57. Soren Singel, Stacy Hicks, Ashley Dawson, Ekokobe Fonkem, Patrick Noonan. MS-23: IMPROVING FORWARD INFUSION PRESSURE IN VASCULAR BRAIN TUMORS USING A DOUBLE CATHETER AND COIL TECHNIQUE. Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v131, https://doi.org/10.1093/neuonc/nou260.22. Published: 01 November 2014.
58. Sanjib Mukherjee, Chander Shekhar peddaboina, Eromata Ebwe, Jahnavi Udaikumar, Ryan Shephard, Karen Newell-Rogers, Soren Singel, Ekokobe Fonkem. ED-20: THE INCIDENCE OF PEDIATRIC BRAIN TUMORS WITHIN THE SCOTT AND WHITE INTEGRATED HEALTHCARE HEALTH SYSTEM. Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v70, https://doi.org/10.1093/neuonc/nou253.20. Published: 01 November 2014.
59. Soren Singel, Ashley Dawson, Kavon Sharifi, Jason Huang, Ekokobe Fonkem, Bohdan Chopko. QL-23: AN ADJUSTED CUMULATIVE SCORING SYSTEM FOR MALIGNANT BRAIN TUMORS. Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v183, https://doi.org/10.1093/neuonc/nou269.22. Published: 01 November 2014.
60. Ryan Shephard, Soren Singel, Ekokobe Fonkem. ED-29: THE INCIDENCE OF ADULT AND PEDIATRIC INTRACRANIAL EPENDYMOMAS WITHIN THE SCOTT AND WHITE INTEGRATED HEALTHCARE SYSTEM. Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v72, https://doi.org/10.1093/neuonc/nou253.29. Published: 01 November 2014.
61. Darin Garrett, Sanjib Mukherjee, Richard Tobin, Susannah Rogers, Stephanie Henderson, Heather Motal, Jessica Kain, Ekokobe Fonkem, M. Karen Newell-Rogers. ET-20: INTERFERING WITH GLIOBLASTOMA MULTIFORME METABOLISM TO COMPLEMENT THERAPEUTIC EFFECTS OF TEMOZOLOMIDE. Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v83, https://doi.org/10.1093/neuonc/nou255.20. Published: 01 November 2014.
62. Sanjib Mukherjee, Richard Tobin, Susannah Rogers, Long Dao, Jessica Kain, Giuseppina Dusio, Soren Singel, Ekokobe Fonkem, M. Karen Newell-Rogers. ET-41: TEMOZOLOMIDE CYTOTOXICITY IS POTENTIATED BY METABOLIC MODIFICATIONS IN GLIOBLASTOMA MULTIFORME (GBM). Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v88, https://doi.org/10.1093/neuonc/nou255.41. Published: 01 November 2014.
63. Ekokobe Fonkem, Kerry O'Mahar, Haydee Becerril, Abigail Bernett, Jared Benge, Daniel Cruz, Richard Phenis. NIH PROMS (Patient Reported Outcomes Measurement Information System) among patients with neoplasms. May 2014Journal of Clinical Oncology. Conference: 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Volume: 32.
64. Shuang Zhou, Fengfei Wang, Shihua Xiang, Eric Wong, Wallace Muhonen, Ekokobe Fonkem, Tze-chen Hsieh, David Li, Ruiwen Zhang, John Shabb, Joseph Wu, Min Wu, Erxi Wu. Identification and clinical prognosis of salinomycin binding targets in neuroblastoma (LB613). Pharmacology and Experimental Therapeutic. Volume28, IssueS1. Experimental Biology 2014 Meeting Abstracts. April 2014. LB613. First published: 01 April 2014 https://doi.org/10.1096/fasebj.28.1_supplement.lb613.
65. Eromata Ebue, Juhee Song, Frank Harris, Nitika Thawani, Pier Luigi DiPatre, M. Karen Newell Rogers, Ekokobe Fonkem. THE INCIDENCE OF ASTROCYTOMA AT AN INTEGRATED HEALTH CARE SYSTEM: THE EXPERIENCE OF SCOTT & WHITE HEALTH CARE SYSTEM. November 2013, Neuro-Oncology. Conference: 4th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology (WFNO)Volume: 15.
66. Paul Bricker, Ekokobe Fonkem. SPECTRUM OF NEUROLOGIC PRESENTATIONS OF INTRAVASCULAR LYMPHOMA: A 643 PATIENT STUDY. November 2013, Neuro-Oncology. Conference: 4th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology (WFNO)Volume: 15.
67. Jennifer Griffin, Richard Tobin, M. Karen Newell Rogers, Eromata Ebwe, Ekokobe Fonkem. A RETROSPECTIVE STUDY: THE INCIDENCE OF GLIOBLASTOMA WITHIN THE SCOTT & WHITE HEALTHCARE INTEGRATED SYSTEM FROM 1976-2011. Conference Paper. November 2013, Neuro-Oncology. Conference: 4th Quadrennial Meeting of the World-Federation-of-Neuro-Oncology (WFNO)Volume: 15.
68. Mary Ellen Bates, Ekokobe Fonkem, Barbara Stout, Stephane Esnault, William W Busse, Paul J Bertics. Interleukin-5 (IL-5) Induces Expression of Lymphotoxin- (LT-) Beta in Human Eosinophils. J ALLERGY CLIN IMMUNOL JANUARY 2002.
69. Marta K. Powell, Giannoula L. Klement, Tina Roffidal, Ekokobe Fonkem, and Johannes E. Wolff. PC-17. PROSPECTIVE CHART REVIEW TO DEVELOP PERSONALIZED TARGETED THERAPIES, PRELIMINARY DATA. CLIN-PEDIATRICS CLINICAL RESEARCH. Neuro-Oncology, Volume 14, Issue suppl_6, October 2012, Pages vi112–vi115, https://doi.org/10.1093/neuonc/nos234. Published: 01 October 2012.
70. Ekokobe Fonkem, David J Robison, Edwin Lok , Shiva Gautam , Eric Wong. The natural history of intravascular lymphoma. Meeting Abstract \| 2012 ASCO Annual Meeting I. LYMPHOMA AND PLASMA CELL DISORDERS. Journal of Clinical Oncology; List of Issues; Volume 30, Issue 15_suppl.
71. Ekokobe Fonkem, D. Robison, Edwin Lok, S. Gautam, E. Wong. The Natural History of Intravascular Lymphoma (P06.020). April 2012Neurology 78(Meeting Abstracts 1): P06.020-P06.020Follow journal. DOI: 10.1212/WNL.78.1_MeetingAbstracts.P06.020
72. Barbara Stout. Ekokobe Fonkem, Mary Ellen Bates, Stephane Esnault, William W Busse, Paul J Bertics. Interleukin-5 Induces Pim-1 and Cyclin D3 Expression in Human Eosinophils. J ALLERGY CLIN IMMUNOL JANUARY 2002.
73. Tejas Ranade, Sami Kaldawi, Zain Ashary, Huiam Mubarak, Ekokobe Fonkem. Treatment Outcomes In Patients With H3K27 M Variant Glioma (P6-9.004). Publication date: 2022/5/3. Source: Neurology. Volume: 98. Issue: 18 Supplement. Publisher: Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
74. Yuan Shan, Sanjib Mukherjee, Ekokobe Fonkem, Danijela Levacic. A Case Report of Cerebellar GBM with H3 K27M Mutation. Publication date: 2019/6/1. Conference: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. Volume 78, Issue 6, Pages 534-534. Publisher: OXFORD UNIV PRESS INC.
75. Solomon Ambe, Damir Nizamutdinov, Ndolembai Njesada, Ekokobe Fonkem. Incidence of Primary Brain and Central Nervous System Tumors Among Hispanic Population in Texas 1995–2013 (P6. 166). Publication date: 2018/4/10. Source: Neurology. Volume 90, Issue 15 Supplement. Publisher: Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
76. Solomon Ambe, Kristopher Lyon, Damir Nizamutdinov, Ekokobe Fonkem. Incidence trends, rates, and ethnic variations of primary CNS tumors in Texas from 1995–2013. (P6. 143). Publication date: 2018/4/10. Source: Neurology. Volume 90, Issue 15 Supplement. Publisher: Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
77. Niloofar Yari, Ethan Benardete, Solomon Ambe, Ekokobe Fonkem. Herpes simplex encephalitis after surgery for solid central nervous system tumors: A case report and systematic review of the literature (P6. 093). Publication date: 2018/4/10. Source: Neurology. Volume 90, Issue 15 Supplement. Publisher: Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
78. Jad Dandashi, Damir Nizamutdinov, Eliana Vasquez, Eileen Stock, Samantha Dayawansa, Jun Zhang, Ekokobe Fonkem, Erxi Wu, Jason Huang. A Retrospective Study to Identify Novel Prognostic Factors for Glioblastoma Patients Survival: Survival Outcomes Prognostication in Glioblastoma Diagnosed Patients (P5. 085). Publication date: 2016/4/5. Source: Neurology. Volume 86, Issue 16 Supplement. Publisher: Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
79. Ekokobe Fonkem, Richard Tobin, Jennifer Griffin, Alex Zuzek, Martha Rogers. METABOLIC DISRUPTION AS A MECHANISM TO POTENTIATE TEMOZOLOMIDE THERAPY INGLIOBLASTOMA MULTIFORME. Publication date: 2013/11/1. Conference: NEURO-ONCOLOGY. Volume 15; Pages 85-86. Publisher: OXFORD UNIV PRESS INC.
80. Paul Bricker, Eric T Wong, Ekokobe Fonkem. Spectrums of Neurologic Presentations of Intravascular Lymphoma (IVL). Publication date: 2013/10/1. Conference: ANNALS OF NEUROLOGY. Volume 74; Pages S86-S86. Publisher WILEY-BLACKWELL.
81. NaTosha N Gatson, Jessica L Williams, Nicole D Powell, Melanie A McClain, Ekokobe Fonkem, Teresa R Hennon, Caroline C Whitacre. Role for Serum Derived Exosomes in Halting CNS Autoimmune Injury: A Model for Pregnancy Suppression of RRMS and PPMS. Publication date: 2011/3/1. Conference: NEUROLOGY. Volume 76; Issue 9; Pages A274-A274.
82. Ashley M. Stokes, Sudarshan Ragunathan, Laura Bell, Ekokobe Fonkem, John Karis, and C. Chad Quarles. Abstract #1073: Comparison of Gadolinium- and Iron-Oxide-based Perfusion Imaging Metrics in Glioblastoma. 2021 ISMRM & SMRT Annual Meeting & Exhibition.15-20 May 2021.
83. Sudarshan Ragunathan, Laura C Bell, Ashley M Stokes, Ekokobe Fonkem, John P Karis, and C Chad Quarles. Abstract #1076: Application of Multiband SENSE SAGE EPI towards DSC MRI of Brain Tumors. 2021 ISMRM & SMRT Annual Meeting & Exhibition.15-20 May 2021.

Database, Video, or Other Research/Clinical Contributions
1. Tv, B. (2023, January 3). “Ask the Doc” with Dr Ekokobe Fonkem, DO from NeuroX [Video]. Vimeo. https://vimeo.com/521049835.
2. The Leadership Blend Live Podcast. (2022, May 11). Surviving & understanding a brain tumor w/ Dr. Joh Evans Coleman and Dr. Ekokobe Fonkem [Video]. YouTube. https://www.youtube.com/watch?v=b1g9Gqq0T0I
3. Maranan, V. (2015, November 19). How One Device May Help Prolong Brain Cancer Patients’ Lives [Video]. https://spectrumlocalnews.com/lifestyles/2015/11/18/how-one-device-may-help-prolong-brain-cancer-patients--lives?cid=share_clip

Patents
1. Apparatuses for detecting and/or destroying abnormal tissue, such as cancer tissue, and related methods. Inventors: samantha dayawansa, jason h. Huang and ekokobe fonkem. Provisional us patent application filed 11/18/2015 by scott & white healthcare, priority date: 11/18/2015. Us application number 62/256,977.
2. Methods for detecting or treating glioblastoma multiforme. Inventors: erxi wu, dan qi, ekokobe fonkem, and jason huang, provisional us patent application filed 12/22/2020. Us application number 63/129,387

© 2024 Clinical & Translational Science Institute
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53223

Publication and ontology data from NCBI | Disclaimer and Copyright

This site is a collaborative effort of the Medical College of Wisconsin and the Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number 2UL1TR001436) at the National Institutes of Health (NIH).

Faculty Collaboration Database

Profiles for MCW, MU, MSOE, UWM, BCW, CW, Froedtert, and VA Faculty